Literature DB >> 10795756

Cytokine production by CAPAN-1 and CAPAN-2 cell lines.

J A Blanchard1, S Barve, S Joshi-Barve, R Talwalker, L K Gates.   

Abstract

Recently, there has been a great deal of interest in the role of cytokines in acute pancreatitis. Serum levels of IL-1, IL-6, and TNF-alpha have been demonstrated to be elevated in acute pancreatitis. We hypothesized that cytokines may be produced primarily by pancreatic parenchymal cells. Reasoning that ductal epithelium is the cell type most likely to be exposed to noxious stimuli in common causes of pancreatitis, such as ERCP and passage of a gallstone, we examined the response of well differentiated pancreatic ductal adenocarcinoma cell lines to stimuli known to stimulate cytokine production in other cells. CAPAN-1 and CAPAN-2 cells were incubated with endotoxin or TNF-alpha. The supernatant was assayed for production of IL-1, IL-6, and IL-8 by ELISA. The cells were assayed for activation of the transcription factor NF-kappaB by electrophoretic mobility shift assay. There was no detectable production of IL-1 by either cell line. CAPAN-1 cells had concentration-dependent production of IL-6 and IL-8 in response to both endotoxin and TNF-alpha. CAPAN-2 cells had concentration-dependent production of IL-6 and IL-8 in response to TNF-alpha. They had low level expression of IL-8 that was unaffected by any concentration of LPS, and no detectable production of IL-6 in response to LPS. These findings suggest that pancreatic duct cells may take an active part in the pathogenesis of acute pancreatitis through the production of cytokines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10795756     DOI: 10.1023/a:1005573024448

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

2.  Inositolphosphoglycans are possible mediators of the glucagon-like peptide 1 (7-36)amide action in the liver.

Authors:  M A Trapote; F Clemente; C Galera; M Morales; A I Alcántara; M I López-Delgado; M L Villanueva-Peñacarrillo; I Valverde
Journal:  J Endocrinol Invest       Date:  1996-02       Impact factor: 4.256

Review 3.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 4.  Interleukin-8, a chemotactic and inflammatory cytokine.

Authors:  M Baggiolini; I Clark-Lewis
Journal:  FEBS Lett       Date:  1992-07-27       Impact factor: 4.124

5.  Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis.

Authors:  T Inagaki; M Hoshino; T Hayakawa; H Ohara; T Yamada; H Yamada; M Iida; T Nakazawa; T Ogasawara; A Uchida; C Hasegawa; M Miyaji; T Takeuchi
Journal:  Pancreas       Date:  1997-01       Impact factor: 3.327

6.  Increased monocyte cytokine production in association with systemic complications in acute pancreatitis.

Authors:  C J McKay; G Gallagher; B Brooks; C W Imrie; J N Baxter
Journal:  Br J Surg       Date:  1996-07       Impact factor: 6.939

7.  Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis.

Authors:  H G Leser; V Gross; C Scheibenbogen; A Heinisch; R Salm; M Lausen; K Rückauer; R Andreesen; E H Farthmann; J Schölmerich
Journal:  Gastroenterology       Date:  1991-09       Impact factor: 22.682

8.  Phosphorylation-regulated low-conductance Cl- channels in a human pancreatic duct cell line.

Authors:  F Becq; E Hollande; M Gola
Journal:  Pflugers Arch       Date:  1993-10       Impact factor: 3.657

9.  Interrelationship between the Na+/glucose cotransporter and CFTR in Caco-2 cells: relevance to cystic fibrosis.

Authors:  C Mailleau; J Capeau; M C Brahimi-Horn
Journal:  J Cell Physiol       Date:  1998-09       Impact factor: 6.384

Review 10.  Interleukin-6 in clinical medicine.

Authors:  J Bauer; F Herrmann
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

View more
  11 in total

1.  Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide.

Authors:  Marc Weeber; Rein Vos; Henny Klein; Lolkje T W De Jong-Van Den Berg; Alan R Aronson; Grietje Molema
Journal:  J Am Med Inform Assoc       Date:  2003-01-28       Impact factor: 4.497

2.  Depression, cytokines, and pancreatic cancer.

Authors:  William Breitbart; Barry Rosenfeld; Kristen Tobias; Hayley Pessin; Geoffrey Y Ku; Jianda Yuan; Jedd Wolchok
Journal:  Psychooncology       Date:  2013-10-18       Impact factor: 3.894

3.  Immunohistochemical localization of interleukin-6 in peripheral human endocrine glands.

Authors:  George Kontogeorgos; Irene Messini; Efi Kyrodimou; Linda Giannikaki; Emmanuel Zois; George Koukoulis; Stylianos Tsagarakis
Journal:  Endocrine       Date:  2002-03       Impact factor: 3.633

4.  Antioxidants inhibit cytokine production and suppress NF-kappaB activation in CAPAN-1 and CAPAN-2 cell lines.

Authors:  J A Blanchard; S Barve; S Joshi-Barve; R Talwalker; L K Gates
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

Review 5.  Pancreatitis after endoscopic retrograde cholangio-pancreatography.

Authors:  Ayman M Abdel Aziz; Glen A Lehman
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

6.  Effect of NF-kappaB and p38 MAPK in activated monocytes/macrophages on pro-inflammatory cytokines of rats with acute pancreatitis.

Authors:  Hong-Shan Liu; Cheng-En Pan; Qing-Guang Liu; Wei Yang; Xue-Min Liu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

7.  Improvement of canine islet yield by donor pancreas infusion with a p38MAPK inhibitor.

Authors:  Taihei Ito; Keiko Omori; Jeffrey Rawson; Ivan Todorov; Sadaki Asari; Akio Kuroda; Jonathan Shintaku; Shin Itakura; Kevin Ferreri; Fouad Kandeel; Yoko Mullen
Journal:  Transplantation       Date:  2008-07-27       Impact factor: 4.939

8.  Metabolic and inflammatory responses after ERCP.

Authors:  Gokhan Adas; Ahu Kemik; Mine Adas; Bora Koc; Emin Gurbuz; Adem Akcakaya; Servet Karahan
Journal:  Int J Biomed Sci       Date:  2013-12

Review 9.  NSAIDs and Acute Pancreatitis: A Systematic Review.

Authors:  Raffaele Pezzilli; Antonio Maria Morselli-Labate; Roberto Corinaldesi
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-10

Review 10.  Epithelial Anion Transport as Modulator of Chemokine Signaling.

Authors:  Andrea Schnúr; Péter Hegyi; Simon Rousseau; Gergely L Lukacs; Guido Veit
Journal:  Mediators Inflamm       Date:  2016-06-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.